London-based GlaxoSmithKline makes Advair at a manufacturing facility in Zebulon. A weak pound benefits Glaxo because it sells most of its drugs outside the United Kingdom.
London-based GlaxoSmithKline makes Advair at a manufacturing facility in Zebulon. A weak pound benefits Glaxo because it sells most of its drugs outside the United Kingdom. Chris Seward cseward@newsobserver.com
London-based GlaxoSmithKline makes Advair at a manufacturing facility in Zebulon. A weak pound benefits Glaxo because it sells most of its drugs outside the United Kingdom. Chris Seward cseward@newsobserver.com

Business

Weak British pound triggered by Brexit could boost GSK earnings

July 13, 2016 4:54 AM

  Comments  

Videos